Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia (original) (raw)

Abstract

1. Peripheral inflammation is associated with the local production of neuroactive inflammatory cytokines and growth factors. These may contribute to inflammatory pain and hyperalgesia by directly or indirectly altering the function or chemical phenotype of responsive primary sensory neurones. 2. To investigate this, inflammation was produced by the intraplantar injection of complete Freund's adjuvant (CFA) in adult rats. This resulted in a significant elevation in interleukin-1 beta (IL-1 beta) and nerve growth factor (NGF) levels in the inflamed tissue and of the peptides, substance P and calcitonin gene-related peptide (CGRP) in the L4 dorsal root ganglion 48 h post CFA injection. 3. The effects of a steroidal (dexamethasone) and a non-steroidal (indomethacin) anti-inflammatory drug on the levels of NGF and IL-1 beta in inflamed tissue were investigated and compared with alterations in behavioural hyperalgesia and neuropeptide expression in sensory neurones. 4. Systemic dexamethasone (120 micrograms kg-1 per day starting the day before the CFA injection) had no effect on the inflammatory hyperalgesia. When the dose was administered 3 times daily, a reduction in mechanical and to a lesser extent thermal sensitivity occurred. Indomethacin at 2 mg kg-1 daily (i.p.) had no effect on the hyperalgesia and a dose of 4 mg kg-1 daily was required to reduce significantly mechanical and thermal hypersensitivity. 5. The increase in NGF produced by the CFA inflammation was prevented by both dexamethasone and indomethacin, but only at the higher dose levels. Dexamethasone at the lower and higher dose regimes diminished the upregulation of IL-1 beta whereas indomethacin had an effect only at the higher dose. 6. The increase in SP and CGRP levels produced by the CFA inflammation was prevented by dexamethasone and indomethacin at the lower and higher dose regimes. 7. Intraplantar injections of IL-1 beta (0.01, 0.1 and 1 ng) produced a brief (6 h) thermal hyperalgesia and an elevation in cutaneous NGF levels which was prevented by pretreatment with human recombinant IL-1 receptor antagonist (IL-1 ra) (0.625 microgram, i.v.). The thermal hyperalgesia but not the NGF elevation produced by intraplantar IL-1 beta (1 ng) was prevented by administration of a polyclonal neutralizing anti-NGF serum. 8. IL-1 ra significantly reduced the mechanical hyperalgesia produced by CFA for 6 h after administration as well as the CFA-induced elevation in NGF levels. Anti-NGF pretreatment substantially reduced CFA-induced mechanical and thermal hyperalgesia without reducing the elevation in IL-1 beta.(ABSTRACT TRUNCATED AT 250 WORDS)

1265

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aloe L., Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res. 1977 Sep 16;133(2):358–366. doi: 10.1016/0006-8993(77)90772-7. [DOI] [PubMed] [Google Scholar]
  2. Arai K. I., Lee F., Miyajima A., Miyatake S., Arai N., Yokota T. Cytokines: coordinators of immune and inflammatory responses. Annu Rev Biochem. 1990;59:783–836. doi: 10.1146/annurev.bi.59.070190.004031. [DOI] [PubMed] [Google Scholar]
  3. Bandtlow C. E., Heumann R., Schwab M. E., Thoenen H. Cellular localization of nerve growth factor synthesis by in situ hybridization. EMBO J. 1987 Apr;6(4):891–899. doi: 10.1002/j.1460-2075.1987.tb04835.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barde Y. A. Trophic factors and neuronal survival. Neuron. 1989 Jun;2(6):1525–1534. doi: 10.1016/0896-6273(89)90040-8. [DOI] [PubMed] [Google Scholar]
  5. Barnes P. J., Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci. 1993 Dec;14(12):436–441. doi: 10.1016/0165-6147(93)90184-l. [DOI] [PubMed] [Google Scholar]
  6. Bianchi M., Sacerdote P., Locatelli L., Mantegazza P., Panerai A. E. Corticotropin releasing hormone, interleukin-1 alpha, and tumor necrosis factor-alpha share characteristics of stress mediators. Brain Res. 1991 Apr 12;546(1):139–142. doi: 10.1016/0006-8993(91)91168-z. [DOI] [PubMed] [Google Scholar]
  7. Bischoff S. C., Dahinden C. A. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood. 1992 May 15;79(10):2662–2669. [PubMed] [Google Scholar]
  8. Chao M. V. Neurotrophin receptors: a window into neuronal differentiation. Neuron. 1992 Oct;9(4):583–593. doi: 10.1016/0896-6273(92)90023-7. [DOI] [PubMed] [Google Scholar]
  9. Crestani F., Seguy F., Dantzer R. Behavioural effects of peripherally injected interleukin-1: role of prostaglandins. Brain Res. 1991 Mar 1;542(2):330–335. doi: 10.1016/0006-8993(91)91587-q. [DOI] [PubMed] [Google Scholar]
  10. Dawson J., Rordorf-Adam C., Geiger T., Towbin H., Kunz S., Nguyen H., Zingel O., Chaplin D., Vosbeck K. Interleukin-1 (IL-1) production in a mouse tissue chamber model of inflammation. II. Identification of (tissue) macrophages as the IL-1 producing cells and the effect of anti-inflammatory drugs. Agents Actions. 1993 Mar;38(3-4):255–264. doi: 10.1007/BF01976218. [DOI] [PubMed] [Google Scholar]
  11. DeLeón M., Coveñas R., Chadi G., Narváez J. A., Fuxe K., Cintra A. Subpopulations of primary sensory neurons show coexistence of neuropeptides and glucocorticoid receptors in the rat spinal and trigeminal ganglia. Brain Res. 1994 Feb 14;636(2):338–342. doi: 10.1016/0006-8993(94)91034-0. [DOI] [PubMed] [Google Scholar]
  12. Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
  13. Donaldson L. F., Harmar A. J., McQueen D. S., Seckl J. R. Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat. Brain Res Mol Brain Res. 1992 Nov;16(1-2):143–149. doi: 10.1016/0169-328x(92)90204-o. [DOI] [PubMed] [Google Scholar]
  14. Donnerer J., Schuligoi R., Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 1992 Aug;49(3):693–698. doi: 10.1016/0306-4522(92)90237-v. [DOI] [PubMed] [Google Scholar]
  15. Eisenberg S. P., Evans R. J., Arend W. P., Verderber E., Brewer M. T., Hannum C. H., Thompson R. C. Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990 Jan 25;343(6256):341–346. doi: 10.1038/343341a0. [DOI] [PubMed] [Google Scholar]
  16. Ferreira S. H., Lorenzetti B. B., Bristow A. F., Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature. 1988 Aug 25;334(6184):698–700. doi: 10.1038/334698a0. [DOI] [PubMed] [Google Scholar]
  17. Ferreira S. H. The role of interleukins and nitric oxide in the mediation of inflammatory pain and its control by peripheral analgesics. Drugs. 1993;46 (Suppl 1):1–9. doi: 10.2165/00003495-199300461-00003. [DOI] [PubMed] [Google Scholar]
  18. Follenfant R. L., Nakamura-Craig M., Henderson B., Higgs G. A. Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia. Br J Pharmacol. 1989 Sep;98(1):41–43. doi: 10.1111/j.1476-5381.1989.tb16860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Friedman W. J., Lärkfors L., Ayer-LeLievre C., Ebendal T., Olson L., Persson H. Regulation of beta-nerve growth factor expression by inflammatory mediators in hippocampal cultures. J Neurosci Res. 1990 Nov;27(3):374–382. doi: 10.1002/jnr.490270316. [DOI] [PubMed] [Google Scholar]
  20. Fukuoka H., Kawatani M., Hisamitsu T., Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res. 1994 Sep 19;657(1-2):133–140. doi: 10.1016/0006-8993(94)90960-1. [DOI] [PubMed] [Google Scholar]
  21. Glass D. J., Yancopoulos G. D. The neurotrophins and their receptors. Trends Cell Biol. 1993 Aug;3(8):262–268. doi: 10.1016/0962-8924(93)90054-5. [DOI] [PubMed] [Google Scholar]
  22. Gold B. G., Mobley W. C., Matheson S. F. Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor. J Neurosci. 1991 Apr;11(4):943–955. doi: 10.1523/JNEUROSCI.11-04-00943.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hart R. P., Shadiack A. M., Jonakait G. M. Substance P gene expression is regulated by interleukin-1 in cultured sympathetic ganglia. J Neurosci Res. 1991 Jul;29(3):282–291. doi: 10.1002/jnr.490290303. [DOI] [PubMed] [Google Scholar]
  24. Hattori A., Tanaka E., Murase K., Ishida N., Chatani Y., Tsujimoto M., Hayashi K., Kohno M. Tumor necrosis factor stimulates the synthesis and secretion of biologically active nerve growth factor in non-neuronal cells. J Biol Chem. 1993 Feb 5;268(4):2577–2582. [PubMed] [Google Scholar]
  25. Heumann R., Korsching S., Bandtlow C., Thoenen H. Changes of nerve growth factor synthesis in nonneuronal cells in response to sciatic nerve transection. J Cell Biol. 1987 Jun;104(6):1623–1631. doi: 10.1083/jcb.104.6.1623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hong D., Byers M. R., Oswald R. J. Dexamethasone treatment reduces sensory neuropeptides and nerve sprouting reactions in injured teeth. Pain. 1993 Nov;55(2):171–181. doi: 10.1016/0304-3959(93)90146-G. [DOI] [PubMed] [Google Scholar]
  27. Horigome K., Pryor J. C., Bullock E. D., Johnson E. M., Jr Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation. J Biol Chem. 1993 Jul 15;268(20):14881–14887. [PubMed] [Google Scholar]
  28. Kar S., Rees R. G., Quirion R. Altered calcitonin gene-related peptide, substance P and enkephalin immunoreactivities and receptor binding sites in the dorsal spinal cord of the polyarthritic rat. Eur J Neurosci. 1994 Mar 1;6(3):345–354. doi: 10.1111/j.1460-9568.1994.tb00277.x. [DOI] [PubMed] [Google Scholar]
  29. Kieselbach G., Troger J., Kaehler C., Saria A. Indomethacin reduces substance P levels in human ocular aqueous humor. Eur J Pharmacol. 1993 Apr 22;235(1):117–119. doi: 10.1016/0014-2999(93)90829-7. [DOI] [PubMed] [Google Scholar]
  30. Korsching S. The neurotrophic factor concept: a reexamination. J Neurosci. 1993 Jul;13(7):2739–2748. doi: 10.1523/JNEUROSCI.13-07-02739.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lee S. W., Tsou A. P., Chan H., Thomas J., Petrie K., Eugui E. M., Allison A. C. Glucocorticoids selectively inhibit the transcription of the interleukin 1 beta gene and decrease the stability of interleukin 1 beta mRNA. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1204–1208. doi: 10.1073/pnas.85.4.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lee Y., Takami K., Kawai Y., Girgis S., Hillyard C. J., MacIntyre I., Emson P. C., Tohyama M. Distribution of calcitonin gene-related peptide in the rat peripheral nervous system with reference to its coexistence with substance P. Neuroscience. 1985 Aug;15(4):1227–1237. doi: 10.1016/0306-4522(85)90265-9. [DOI] [PubMed] [Google Scholar]
  33. Leon A., Buriani A., Dal Toso R., Fabris M., Romanello S., Aloe L., Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3739–3743. doi: 10.1073/pnas.91.9.3739. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lewin G. R., Mendell L. M. Nerve growth factor and nociception. Trends Neurosci. 1993 Sep;16(9):353–359. doi: 10.1016/0166-2236(93)90092-z. [DOI] [PubMed] [Google Scholar]
  35. Lewin G. R., Ritter A. M., Mendell L. M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci. 1993 May;13(5):2136–2148. doi: 10.1523/JNEUROSCI.13-05-02136.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lewin G. R., Rueff A., Mendell L. M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci. 1994 Dec 1;6(12):1903–1912. doi: 10.1111/j.1460-9568.1994.tb00581.x. [DOI] [PubMed] [Google Scholar]
  37. Libby P., Ordovas J. M., Auger K. R., Robbins A. H., Birinyi L. K., Dinarello C. A. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol. 1986 Aug;124(2):179–185. [PMC free article] [PubMed] [Google Scholar]
  38. Lindholm D., Heumann R., Hengerer B., Thoenen H. Interleukin 1 increases stability and transcription of mRNA encoding nerve growth factor in cultured rat fibroblasts. J Biol Chem. 1988 Nov 5;263(31):16348–16351. [PubMed] [Google Scholar]
  39. Lindholm D., Heumann R., Meyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 1987 Dec 17;330(6149):658–659. doi: 10.1038/330658a0. [DOI] [PubMed] [Google Scholar]
  40. Lindholm Dan, Hengerer Bastian, Heumann Rolf, Carroll Patrick, Thoenen Hans. Glucocorticoid Hormones Negatively Regulate Nerve Growth Factor Expression In Vivo and in Cultured Rat Fibroblasts. Eur J Neurosci. 1990;2(9):795–801. doi: 10.1111/j.1460-9568.1990.tb00471.x. [DOI] [PubMed] [Google Scholar]
  41. Lindsay R. M., Harmar A. J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature. 1989 Jan 26;337(6205):362–364. doi: 10.1038/337362a0. [DOI] [PubMed] [Google Scholar]
  42. Lindsay R. M., Lockett C., Sternberg J., Winter J. Neuropeptide expression in cultures of adult sensory neurons: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor. Neuroscience. 1989;33(1):53–65. doi: 10.1016/0306-4522(89)90310-2. [DOI] [PubMed] [Google Scholar]
  43. MacLean D. B., Bennett B., Morris M., Wheeler F. B. Differential regulation of calcitonin gene-related peptide and substance P in cultured neonatal rat vagal sensory neurons. Brain Res. 1989 Jan 30;478(2):349–355. doi: 10.1016/0006-8993(89)91515-1. [DOI] [PubMed] [Google Scholar]
  44. Maier J. A., Hla T., Maciag T. Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem. 1990 Jul 5;265(19):10805–10808. [PubMed] [Google Scholar]
  45. Masferrer J. L., Seibert K., Zweifel B., Needleman P. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc Natl Acad Sci U S A. 1992 May 1;89(9):3917–3921. doi: 10.1073/pnas.89.9.3917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Matsuda H., Coughlin M. D., Bienenstock J., Denburg J. A. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6508–6512. doi: 10.1073/pnas.85.17.6508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Matsuoka I., Meyer M., Thoenen H. Cell-type-specific regulation of nerve growth factor (NGF) synthesis in non-neuronal cells: comparison of Schwann cells with other cell types. J Neurosci. 1991 Oct;11(10):3165–3177. doi: 10.1523/JNEUROSCI.11-10-03165.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Mazurek N., Weskamp G., Erne P., Otten U. Nerve growth factor induces mast cell degranulation without changing intracellular calcium levels. FEBS Lett. 1986 Mar 31;198(2):315–320. doi: 10.1016/0014-5793(86)80428-8. [DOI] [PubMed] [Google Scholar]
  49. McQuay H. J., Carroll D., Moore R. A. Postoperative orthopaedic pain--the effect of opiate premedication and local anaesthetic blocks. Pain. 1988 Jun;33(3):291–295. doi: 10.1016/0304-3959(88)90287-4. [DOI] [PubMed] [Google Scholar]
  50. Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. J., Vane J. R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11693–11697. doi: 10.1073/pnas.90.24.11693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Movat H. Z. Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury. J Lab Clin Med. 1987 Dec;110(6):668–681. [PubMed] [Google Scholar]
  52. Noguchi K., Morita Y., Kiyama H., Ono K., Tohyama M. A noxious stimulus induces the preprotachykinin-A gene expression in the rat dorsal root ganglion: a quantitative study using in situ hybridization histochemistry. Brain Res. 1988 Aug;464(1):31–35. doi: 10.1016/0169-328x(88)90015-0. [DOI] [PubMed] [Google Scholar]
  53. Oku R., Satoh M., Takagi H. Release of substance P from the spinal dorsal horn is enhanced in polyarthritic rats. Neurosci Lett. 1987 Mar 9;74(3):315–319. doi: 10.1016/0304-3940(87)90316-8. [DOI] [PubMed] [Google Scholar]
  54. Otten U., Ehrhard P., Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci U S A. 1989 Dec;86(24):10059–10063. doi: 10.1073/pnas.86.24.10059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Pearce F. L., Thompson H. L. Some characteristics of histamine secretion from rat peritoneal mast cells stimulated with nerve growth factor. J Physiol. 1986 Mar;372:379–393. doi: 10.1113/jphysiol.1986.sp016014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Perkins M. N., Kelly D. Interleukin-1 beta induced-desArg9bradykinin-mediated thermal hyperalgesia in the rat. Neuropharmacology. 1994 May;33(5):657–660. doi: 10.1016/0028-3908(94)90171-6. [DOI] [PubMed] [Google Scholar]
  57. Rich K. M., Luszczynski J. R., Osborne P. A., Johnson E. M., Jr Nerve growth factor protects adult sensory neurons from cell death and atrophy caused by nerve injury. J Neurocytol. 1987 Apr;16(2):261–268. doi: 10.1007/BF01795309. [DOI] [PubMed] [Google Scholar]
  58. Rich K. M., Yip H. K., Osborne P. A., Schmidt R. E., Johnson E. M., Jr Role of nerve growth factor in the adult dorsal root ganglia neuron and its response to injury. J Comp Neurol. 1984 Nov 20;230(1):110–118. doi: 10.1002/cne.902300110. [DOI] [PubMed] [Google Scholar]
  59. Rome L. H., Lands W. E. Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. Proc Natl Acad Sci U S A. 1975 Dec;72(12):4863–4865. doi: 10.1073/pnas.72.12.4863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Salmon J. A., Simmons P. M., Moncada S. The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammation. J Pharm Pharmacol. 1983 Dec;35(12):808–813. doi: 10.1111/j.2042-7158.1983.tb02901.x. [DOI] [PubMed] [Google Scholar]
  61. Schaible H. G., Jarrott B., Hope P. J., Duggan A. W. Release of immunoreactive substance P in the spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes. Brain Res. 1990 Oct 8;529(1-2):214–223. doi: 10.1016/0006-8993(90)90830-5. [DOI] [PubMed] [Google Scholar]
  62. Schweizer A., Feige U., Fontana A., Müller K., Dinarello C. A. Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels. Agents Actions. 1988 Dec;25(3-4):246–251. doi: 10.1007/BF01965025. [DOI] [PubMed] [Google Scholar]
  63. Schäfer M. K., Nohr D., Krause J. E., Weihe E. Inflammation-induced upregulation of NK1 receptor mRNA in dorsal horn neurones. Neuroreport. 1993 Aug;4(8):1007–1010. doi: 10.1097/00001756-199308000-00003. [DOI] [PubMed] [Google Scholar]
  64. Shadiack A. M., Hart R. P., Carlson C. D., Jonakait G. M. Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF). J Neurosci. 1993 Jun;13(6):2601–2609. doi: 10.1523/JNEUROSCI.13-06-02601.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Shiue S. T., Thrall R. S. Effect of corticosteroid therapy on the acute injury and recovery stage of oleic acid induced lung injury in the rat. Exp Lung Res. 1991 May-Jun;17(3):629–638. doi: 10.3109/01902149109062870. [DOI] [PubMed] [Google Scholar]
  66. Siminoski K., Murphy R. A., Rennert P., Heinrich G. Cortisone, testosterone, and aldosterone reduce levels of nerve growth factor messenger ribonucleic acid in L-929 fibroblasts. Endocrinology. 1987 Oct;121(4):1432–1437. doi: 10.1210/endo-121-4-1432. [DOI] [PubMed] [Google Scholar]
  67. Sivilotti L., Woolf C. J. The contribution of GABAA and glycine receptors to central sensitization: disinhibition and touch-evoked allodynia in the spinal cord. J Neurophysiol. 1994 Jul;72(1):169–179. doi: 10.1152/jn.1994.72.1.169. [DOI] [PubMed] [Google Scholar]
  68. Smith G. D., Harmar A. J., McQueen D. S., Seckl J. R. Increase in substance P and CGRP, but not somatostatin content of innervating dorsal root ganglia in adjuvant monoarthritis in the rat. Neurosci Lett. 1992 Mar 30;137(2):257–260. doi: 10.1016/0304-3940(92)90417-6. [DOI] [PubMed] [Google Scholar]
  69. Smith G. D., Seckl J. R., Sheward W. J., Bennie J. G., Carroll S. M., Dick H., Harmar A. J. Effect of adrenalectomy and dexamethasone on neuropeptide content of dorsal root ganglia in the rat. Brain Res. 1991 Nov 8;564(1):27–30. doi: 10.1016/0006-8993(91)91347-4. [DOI] [PubMed] [Google Scholar]
  70. Snyder D. S., Unanue E. R. Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol. 1982 Nov;129(5):1803–1805. [PubMed] [Google Scholar]
  71. Stjernschantz J., Gregerson D., Bausher L., Sears M. Enzyme-linked immunosorbent assay of substance P: a study in the eye. J Neurochem. 1982 May;38(5):1323–1328. doi: 10.1111/j.1471-4159.1982.tb07908.x. [DOI] [PubMed] [Google Scholar]
  72. Stucky C. L., Galeazza M. T., Seybold V. S. Time-dependent changes in Bolton-Hunter-labeled 125I-substance P binding in rat spinal cord following unilateral adjuvant-induced peripheral inflammation. Neuroscience. 1993 Nov;57(2):397–409. doi: 10.1016/0306-4522(93)90071-m. [DOI] [PubMed] [Google Scholar]
  73. Taiwo Y. O., Levine J. D., Burch R. M., Woo J. E., Mobley W. C. Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5144–5148. doi: 10.1073/pnas.88.12.5144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Taktak Y. S., Selkirk S., Bristow A. F., Carpenter A., Ball C., Rafferty B., Poole S. Assay of pyrogens by interleukin-6 release from monocytic cell lines. J Pharm Pharmacol. 1991 Aug;43(8):578–582. doi: 10.1111/j.2042-7158.1991.tb03540.x. [DOI] [PubMed] [Google Scholar]
  75. Thompson S. W., Dray A., Urban L. Injury-induced plasticity of spinal reflex activity: NK1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitro. J Neurosci. 1994 Jun;14(6):3672–3687. doi: 10.1523/JNEUROSCI.14-06-03672.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. Thorpe L. W., Perez-Polo J. R. The influence of nerve growth factor on the in vitro proliferative response of rat spleen lymphocytes. J Neurosci Res. 1987;18(1):134–139. doi: 10.1002/jnr.490180120. [DOI] [PubMed] [Google Scholar]
  77. Treede R. D., Meyer R. A., Raja S. N., Campbell J. N. Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol. 1992;38(4):397–421. doi: 10.1016/0301-0082(92)90027-c. [DOI] [PubMed] [Google Scholar]
  78. Vane J. R., Mitchell J. A., Appleton I., Tomlinson A., Bishop-Bailey D., Croxtall J., Willoughby D. A. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2046–2050. doi: 10.1073/pnas.91.6.2046. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Varilek G. W., Weinstock J. V., Pantazis N. J. Isolated hepatic granulomas from mice infected with Schistosoma mansoni contain nerve growth factor. Infect Immun. 1991 Dec;59(12):4443–4449. doi: 10.1128/iai.59.12.4443-4449.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Watkins L. R., Wiertelak E. P., Goehler L. E., Smith K. P., Martin D., Maier S. F. Characterization of cytokine-induced hyperalgesia. Brain Res. 1994 Aug 15;654(1):15–26. doi: 10.1016/0006-8993(94)91566-0. [DOI] [PubMed] [Google Scholar]
  81. Weskamp G., Otten U. An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and in peripheral tissues. J Neurochem. 1987 Jun;48(6):1779–1786. doi: 10.1111/j.1471-4159.1987.tb05736.x. [DOI] [PubMed] [Google Scholar]
  82. Woolf C. J. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983 Dec 15;306(5944):686–688. doi: 10.1038/306686a0. [DOI] [PubMed] [Google Scholar]
  83. Woolf C. J. Generation of acute pain: central mechanisms. Br Med Bull. 1991 Jul;47(3):523–533. doi: 10.1093/oxfordjournals.bmb.a072490. [DOI] [PubMed] [Google Scholar]
  84. Woolf C. J., Safieh-Garabedian B., Ma Q. P., Crilly P., Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 1994 Sep;62(2):327–331. doi: 10.1016/0306-4522(94)90366-2. [DOI] [PubMed] [Google Scholar]
  85. Yoshida K., Gage F. H. Cooperative regulation of nerve growth factor synthesis and secretion in fibroblasts and astrocytes by fibroblast growth factor and other cytokines. Brain Res. 1992 Jan 8;569(1):14–25. doi: 10.1016/0006-8993(92)90364-f. [DOI] [PubMed] [Google Scholar]